| Stage | CSCO | % of rev | FFIV | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $17.3B | 100.00% | $865M | 100.00% | CSCO ×19.94 |
| Gross profit | $11.1B | 64.13% | $712M | 82.25% | FFIV +18.1pp |
| Operating income | $4.3B | 24.72% | $213M | 24.65% | CSCO +0.1pp |
| Pre-tax income | $4.9B | 28.59% | $226M | 26.15% | CSCO +2.4pp |
| Net income | $3.9B | 22.37% | $208M | 24.07% | FFIV +1.7pp |
| Stage | CSCO | FFIV | Gap · A − B |
|---|---|---|---|
| Revenue | $17.3B100.00% | $865M100.00% | CSCO ×19.94 |
| Gross profit | 64.13%$11.1B | 82.25%$712M | FFIV +18.1pp |
| Operating income | 24.72%$4.3B | 24.65%$213M | CSCO +0.1pp |
| Pre-tax income | 28.59%$4.9B | 26.15%$226M | CSCO +2.4pp |
| Net income |
| 22.37%$3.9B |
| 24.07%$208M |
| FFIV +1.7pp |
No shared counterparties.